Corcept Therapeutics Inc (NASDAQ:CORT)

16.99
Delayed Data
As of Apr 25
 -0.35 / -2.02%
Today’s Change
8.99
Today|||52-Week Range
25.96
-5.92%
Year-to-Date
No recent news for Corcept Therapeutics Inc.

Today’s Trading

Previous close17.34
Today’s open17.28
Day’s range16.66 - 17.38
Volume952,721
Average volume (3 months)2,010,551
Market cap$1.9B
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+1,385.71%
Earnings growth (this year)-13.46%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+95.77%
P/E ratio16.3
Price/Sales14.13
Price/Book9.94

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+0.03+0.13%
CBMCambrex Corp+0.10+0.19%
ARRYArray Biopharma Inc+0.02+0.14%
RGENRepligen Corp+0.10+0.27%
Data as of 4:01pm ET, 04/25/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$0.22
Annual revenue (last year)$159.2M
Annual profit (last year)$129.1M
Net profit margin81.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts